# FDA Inspection 1206399 - Relign Corp - May 17, 2023

Source: https://www.keypedia.com/records/fda_inspections/relign-corp/179c64e5-a421-45fb-a5c5-dc60f95bd27a
Source feed: FDA_Inspections

> FDA Inspection 1206399 for Relign Corp on May 17, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1206399
- Company Name: Relign Corp
- Inspection Date: 2023-05-17
- Classification: No Action Indicated (NAI)
- Project Area: Postmarket Assurance: Devices
- Product Type: Devices
- Office Name: Center for Devices and Radiological Health

## Related Documents

- [FDA Inspection 1206399 - 2023-05-17](https://www.keypedia.com/records/fda_inspections/relign-corp/3d1a026a-50b8-47c6-b900-cccda10a2d96)

Company: https://www.keypedia.com/companies/relign-corp/601b1bb4-cdc4-4d2c-ae11-b0c73b0d3cef

Office: https://www.keypedia.com/offices/center-for-devices-and-radiological-health/9d89aff6-e435-4764-87be-f58c01aca7f7